Alzheimer's disease

R&D

September was Alzheimer’s Month, and with that in mind pharmaphorum spoke to leaders at two biotechs about latest developments in the field.

News

The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose dementia more quickly.

News

UK Prime Minister Andy Burnham, who lost his father to Alzheimer's last week, has been urged to implement a "cancer-style" reform of dementia care.

R&D

As we mark World Alzheimer’s Day, it is worth reflecting on the progress made in recent years.

News

The PrevenTRON trial of Roche's Brainshuttle drug trontinemab in preclinical Alzheimer's disease has gotten underway in the UK.

News

Roche has won US FDA clearance for a blood test that could move Alzheimer’s biomarker testing further into primary care.